【24h】

Complete remission in severe lupus nephritis: Assessing the rate of loss in proteinuria

机译:重度狼疮肾炎的完全缓解:评估蛋白尿的流失率

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background The prognosis of severe lupus nephritis (SLN) is improved in patients attaining a complete remission (CR). The time to remission ranges from 10 to 16 months with many patients not attaining a CR until after 12 months. We assessed whether the rate of loss in proteinuria (UPro) is predictive of a CR in SLN patients. Methods We studied 85 adult patients in the prospective controlled trial of plasmapheresis in SLN (New England Journal of Medicine 1992). All patients had International Society of Nephrology/Renal Pathology Society Class IV ± Class V lesions. All patients received prednisone and oral cyclophosphamide and 39 patients received plasmapheresis. A CR was defined by a serum creatinine (SCr) of ≤1.4 mg/dL and UPro of ≤0.33 g/day. The change in UPro in gram per day per week was determined at 3 and 6 months from entry to the study. Results A CR was attained in 37 patients (44%) by 16 ± 14 months. The level of UPro at baseline was similar in CR and no remission (NR) patients (5.5 versus 6.4 g/day), but CR patients had a lower SCr (1.2 versus 2.4, P < 0.0001). At 6 months, the rate of change of UPro was higher at (-)0.224 g/day/week in CR patients and (-)0.107 g/day/week in NR patients (P = 0.01) and a 50% reduction in UPro was seen in 78% of CR patients but only 42% of NR patients (P = 0.009). The time to a CR was ≤12 months in 19 patients and >12 months in 18 patients. The baseline SCr was similar among the two groups. However, UPro at baseline was lower in patients with CR in ≤12 months (3.9 ± 2.7 versus 7.2 ± 3.0 g/day, P = 0.001) but the proportion of patients with membranous glomerulonephritis was similar (16 versus 22%). The rate of change in UPro at 6 months was similar at (-)0.214 g/day/week in patients with CR ≤12 months and (-)0.235 g/day/week in those with CR >12 months (P = 0.6). At 6 months, a 50% reduction in UPro was also similar in the two groups (84 versus 72%, P = 0.4). Additionally, the rate of change in UPro at 3 and 6 months was similar within each group. Conclusions The rate of change in proteinuria at 6 months is significantly greater in patients attaining a CR relative to NR patients but similar in patients with a CR in ≤12 months or >12 months. Thus, the rate of loss of UPro at 6 months may help in predicting which patients will attain a CR.
机译:背景:获得完全缓解(CR)的患者重度狼疮性肾炎(SLN)的预后得到改善。缓解时间为10到16个月不等,许多患者直到12个月后才达到CR。我们评估了蛋白尿流失率(UPro)是否可预测SLN患者的CR。方法我们在SLN血浆置换术的前瞻性对照试验中研究了85名成年患者(新英格兰医学杂志,1992年)。所有患者均患有国际肾脏病学会/肾脏病理学会IV级±V级病变。所有患者均接受泼尼松和口服环磷酰胺治疗,39例患者接受血浆置换术。 CR的定义为血清肌酐(SCr)≤1.4mg / dL和UPro≤0.33g / day。在进入研究后的3个月和6个月内,确定每周每周ProPro的克数变化。结果到16±14个月时,有37例患者(44%)获得了CR。 CR和无缓解(NR)患者的基线时UPro水平相似(5.5对6.4 g /天),但CR患者的SCr较低(1.2对2.4,P <0.0001)。在6个月时,CR患者的UPro变化率较高,为(-)0.224 g /天/周,而NR患者为(-)0.107 g /天/周(P = 0.01),并且UPro降低了50%在78%的CR患者中观察到此现象,而在NR患者中只有42%(P = 0.009)。 CR的时间在19例中≤12个月,在18例中> 12个月。两组之间的基线SCr相似。但是,CR≤12个月的患者在基线时的UPro较低(3.9±2.7对/7.2±3.0 g /天,P = 0.001),但膜性肾小球性肾炎患者的比例相似(16%对22%)。 CR≤12个月的患者在6个月时UPro的变化率与(-)0.214 g /天/周相似,而CR> 12个月的患者的UPro变化率与(-)0.235 g /天/周相似(P = 0.6) 。在6个月时,两组的UPro降低50%也是相似的(84对72%,P = 0.4)。此外,每个组在3个月和6个月时UPro的变化率相似。结论获得CR的患者相对于NR患者,在6个月时蛋白尿的变化率明显更高,但在≤12个月或> 12个月中,CR患者的蛋白尿变化率相似。因此,6个月时UPro的丢失率可能有助于预测哪些患者将获得CR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号